Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study

[1] Lyons CA(1994)Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors Hum Reprod 9 792-799

[2] Wheeler CA(2000)Distinction between early and late ovarian hyperstimulation syndrome Fertil Steril 73 901-907

[3] Frishman GN(2003)Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures Hum Reprod Update 9 275-289

[4] Hackett RJ(1992)Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment Fertil Steril 58 249-261

[5] Seifer DB(1993)Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy Obstet Gynecol 81 108-111

[6] Haning RV(2010)Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 389-400

[7] Mathur RS(1995)Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome Hum Reprod 10 811-814

[8] Akande AV(1991)Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups Hum Reprod 6 1395-1399

[9] Keay SD(2010)IVF outcome in women with PCOS, PCO and normal ovarian morphology Eur J Obstet Gynecol Reprod Biol 149 68-71

[10] Hunt LP(2009)Symposium: Update on prediction and management of OHSS A modern classification of OHSS Reprod Biomed Online 19 28-32

[1] Lyons CA(1994)Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors Hum Reprod 9 792-799

[2] Wheeler CA(2000)Distinction between early and late ovarian hyperstimulation syndrome Fertil Steril 73 901-907

[3] Frishman GN(2003)Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures Hum Reprod Update 9 275-289

[4] Hackett RJ(1992)Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment Fertil Steril 58 249-261

[5] Seifer DB(1993)Management of severe ovarian hyperstimulation syndrome by ascitic fluid aspiration and intensive intravenous fluid therapy Obstet Gynecol 81 108-111

[6] Haning RV(2010)Preventing ovarian hyperstimulation syndrome: guidance for the clinician Fertil Steril 94 389-400

[7] Mathur RS(1995)Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome Hum Reprod 10 811-814

[8] Akande AV(1991)Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups Hum Reprod 6 1395-1399

[9] Keay SD(2010)IVF outcome in women with PCOS, PCO and normal ovarian morphology Eur J Obstet Gynecol Reprod Biol 149 68-71

[10] Hunt LP(2009)Symposium: Update on prediction and management of OHSS A modern classification of OHSS Reprod Biomed Online 19 28-32